RU2015129310A - Таблетки с улучшенным приёмом и хорошей устойчивостью при хранении - Google Patents
Таблетки с улучшенным приёмом и хорошей устойчивостью при хранении Download PDFInfo
- Publication number
- RU2015129310A RU2015129310A RU2015129310A RU2015129310A RU2015129310A RU 2015129310 A RU2015129310 A RU 2015129310A RU 2015129310 A RU2015129310 A RU 2015129310A RU 2015129310 A RU2015129310 A RU 2015129310A RU 2015129310 A RU2015129310 A RU 2015129310A
- Authority
- RU
- Russia
- Prior art keywords
- tablet according
- mass
- pyrantel
- necessary
- mixture
- Prior art date
Links
- 239000013543 active substance Substances 0.000 claims 4
- 235000013372 meat Nutrition 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 claims 3
- 229960005134 pyrantel Drugs 0.000 claims 3
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 claims 2
- HMCCXLBXIJMERM-UHFFFAOYSA-N Febantel Chemical compound C1=C(NC(NC(=O)OC)=NC(=O)OC)C(NC(=O)COC)=CC(SC=2C=CC=CC=2)=C1 HMCCXLBXIJMERM-UHFFFAOYSA-N 0.000 claims 2
- 229960005282 febantel Drugs 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 229960002957 praziquantel Drugs 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 229920000881 Modified starch Polymers 0.000 claims 1
- AQXXZDYPVDOQEE-MXDQRGINSA-N Pyrantel pamoate Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1.C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 AQXXZDYPVDOQEE-MXDQRGINSA-N 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000007908 dry granulation Methods 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000019426 modified starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (16)
1. Таблетка для борьбы с заболеваниями у животных, содержащая:
- по меньшей мере одно фармацевтическое активное вещество,
- по меньшей мере 28% масс. мясного ароматизатора и
- по меньшей мере 2% масс. стабилизирующего средства.
2. Таблетка по п. 1, содержащая по меньшей мере 30% масс. мясного ароматизатора.
3. Таблетка по п. 1, содержащая от 3 до 8% масс. стабилизирующего средства.
4. Таблетка по п. 1, дополнительно содержащая крахмал или производное крахмала в качестве наполнителя.
5. Таблетка по п. 1, дополнительно содержащая лактозу.
6. Таблетка по одному из пп. 1-5, содержащая в качестве фармацевтического активного вещества соединение, выбираемое из группы, включающей в себя фебантел, празиквантел и пирантел.
7. Таблетка по п. 6, содержащая фебантел, празиквантел и пирантел.
8. Таблетка по п. 6, причем пирантел присутствует как эмбонат пирантела.
9. Способ изготовления таблетки по одному из пп. 1-8, при котором
(a) активное вещество или активные вещества, а также при необходимости другие вспомогательные вещества, смешивают, гранулируют, а этот гранулят при необходимости просеивают,
(b) мясной ароматизатор, при необходимости с другими вспомогательными веществами, гомогенно смешивают и подвергают сухому гранулированию,
(c) к смеси из (а) и (b) при необходимости добавляют другие вспомогательные вещества, и все обрабатывают до гомогенной, пригодной к таблетированию смеси, и
(d) после этого смесь перерабатывают с получением таблеток.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12198101.3 | 2012-12-19 | ||
| EP12198101 | 2012-12-19 | ||
| PCT/EP2013/076878 WO2014095845A1 (de) | 2012-12-19 | 2013-12-17 | Tabletten mit verbesserter akzeptanz und guter lagerstabilität |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019118597A Division RU2799052C1 (ru) | 2012-12-19 | 2013-12-17 | Таблетки с улучшенным приёмом и хорошей устойчивостью при хранении |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2015129310A true RU2015129310A (ru) | 2017-01-24 |
| RU2693005C2 RU2693005C2 (ru) | 2019-07-01 |
Family
ID=47458712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015129310A RU2693005C2 (ru) | 2012-12-19 | 2013-12-17 | Таблетки с улучшенным приёмом и хорошей устойчивостью при хранении |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US10543170B2 (ru) |
| EP (1) | EP2934490B1 (ru) |
| JP (1) | JP6393274B2 (ru) |
| KR (1) | KR102253847B1 (ru) |
| CN (1) | CN105025885B (ru) |
| AU (1) | AU2013361760B2 (ru) |
| CA (1) | CA2895254C (ru) |
| CL (1) | CL2015001685A1 (ru) |
| CR (1) | CR20150321A (ru) |
| DO (2) | DOP2015000150A (ru) |
| EC (1) | ECSP15026203A (ru) |
| ES (1) | ES2848394T3 (ru) |
| HK (1) | HK1216856A1 (ru) |
| IL (1) | IL239297B (ru) |
| MX (1) | MX2015007640A (ru) |
| MY (1) | MY175703A (ru) |
| NZ (1) | NZ708741A (ru) |
| PH (1) | PH12015501390A1 (ru) |
| PT (1) | PT2934490T (ru) |
| RU (1) | RU2693005C2 (ru) |
| SV (1) | SV2015004997A (ru) |
| UA (1) | UA118748C2 (ru) |
| WO (1) | WO2014095845A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013361760B2 (en) * | 2012-12-19 | 2018-07-05 | Bayer Animal Health Gmbh | Tablets with improved acceptance and good storage stability |
| CN106580896A (zh) * | 2016-12-07 | 2017-04-26 | 成都乾坤动物药业股份有限公司 | 一种非班太尔分散片及其制备方法 |
| KR20190093571A (ko) | 2016-12-09 | 2019-08-09 | 바이엘 애니멀 헬스 게엠베하 | 제약 제제 및 그의 제조 방법 |
| BR112021004218A2 (pt) * | 2018-09-05 | 2021-05-18 | Zoetis Services Llc | composição veterinária de comprimido mastigável duro e palatável e uso da mesma para tratar ou prevenir uma infecção ou infestação parasitária em um animal |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5746986A (en) | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| US4670444B1 (en) | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
| US4472405A (en) | 1982-11-12 | 1984-09-18 | Riker Laboratories, Inc. | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
| US4730000A (en) | 1984-04-09 | 1988-03-08 | Abbott Laboratories | Quinoline antibacterial compounds |
| AT392789B (de) | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
| IN166416B (ru) | 1985-09-18 | 1990-05-05 | Pfizer | |
| DE3705227A1 (de) | 1987-02-19 | 1988-09-01 | Bayer Ag | Anthelminthische wirkstoffkombinationen |
| FR2715803B3 (fr) | 1994-02-04 | 1996-05-10 | Attali Jean Claude | Leurre et procédé facilitant la prise de médicaments par certains animaux et en particulier par les chiens. |
| DE670160T1 (de) | 1994-03-01 | 1996-03-14 | Gergely, Gerhard, Dr., Wien | Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung. |
| DE19520275A1 (de) | 1995-06-02 | 1996-12-05 | Bayer Ag | Endoparasitizide Mittel |
| US20040180034A1 (en) | 2003-03-10 | 2004-09-16 | Lyn Hughes | Anthelmintic resinates and a method for their preparation |
| DE10328666A1 (de) | 2003-06-26 | 2005-01-13 | Bayer Healthcare Ag | Tabletten enthaltend Geschmacks-und/oder Aromastoffe |
| AR045142A1 (es) * | 2003-07-30 | 2005-10-19 | Novartis Ag | Composicion veterinaria masticable ductil de buen sabor |
| GB2407498B (en) | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
| DE10351448A1 (de) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| DE102004011512B4 (de) * | 2004-03-08 | 2022-01-13 | Boehringer Ingelheim Vetmedica Gmbh | Pharmazeutische Zubereitung enthaltend Pimobendan |
| US7348027B2 (en) | 2005-04-08 | 2008-03-25 | Bayer Healthcare Llc | Taste masked veterinary formulation |
| JP2007269716A (ja) * | 2006-03-31 | 2007-10-18 | Sato Pharmaceutical Co Ltd | 塩酸セチリジン含有粒子 |
| DE102008022520A1 (de) * | 2008-05-07 | 2009-11-12 | Bayer Animal Health Gmbh | Feste Arzneimittelformulierung mit verzögerter Freisetzung |
| JP5296456B2 (ja) * | 2008-08-26 | 2013-09-25 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
| WO2010132286A1 (en) | 2009-05-12 | 2010-11-18 | Wyeth Llc | Orally administered tablet formulation of an antianxiolytic compound |
| GB2475701B (en) * | 2009-11-26 | 2011-10-19 | Michael Hilary Burke | A process for the preparation of an orally administered anthelmintic unit dose tablet |
| CN103200930A (zh) | 2010-10-12 | 2013-07-10 | 拜耳知识产权有限责任公司 | 非淀粉基软咀嚼品 |
| AU2013217633B2 (en) * | 2012-02-06 | 2017-01-12 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof |
| AU2013361760B2 (en) * | 2012-12-19 | 2018-07-05 | Bayer Animal Health Gmbh | Tablets with improved acceptance and good storage stability |
| GB201413832D0 (en) * | 2014-08-05 | 2014-09-17 | Tate & Lyle Ingredients | Starch compositions useful for thickening aqueous liquids |
-
2013
- 2013-12-17 AU AU2013361760A patent/AU2013361760B2/en active Active
- 2013-12-17 US US14/653,676 patent/US10543170B2/en active Active
- 2013-12-17 KR KR1020157016286A patent/KR102253847B1/ko active IP Right Grant
- 2013-12-17 CA CA2895254A patent/CA2895254C/en active Active
- 2013-12-17 ES ES13805906T patent/ES2848394T3/es active Active
- 2013-12-17 PT PT138059068T patent/PT2934490T/pt unknown
- 2013-12-17 JP JP2015548443A patent/JP6393274B2/ja active Active
- 2013-12-17 RU RU2015129310A patent/RU2693005C2/ru active
- 2013-12-17 EP EP13805906.8A patent/EP2934490B1/de active Active
- 2013-12-17 MX MX2015007640A patent/MX2015007640A/es active IP Right Grant
- 2013-12-17 NZ NZ70874113A patent/NZ708741A/en unknown
- 2013-12-17 WO PCT/EP2013/076878 patent/WO2014095845A1/de active Application Filing
- 2013-12-17 CN CN201380067386.1A patent/CN105025885B/zh active Active
- 2013-12-17 MY MYPI2015702037A patent/MY175703A/en unknown
- 2013-12-17 UA UAA201507065A patent/UA118748C2/uk unknown
-
2015
- 2015-06-09 IL IL239297A patent/IL239297B/en unknown
- 2015-06-15 DO DO2015000150A patent/DOP2015000150A/es unknown
- 2015-06-16 CL CL2015001685A patent/CL2015001685A1/es unknown
- 2015-06-16 SV SV2015004997A patent/SV2015004997A/es unknown
- 2015-06-17 PH PH12015501390A patent/PH12015501390A1/en unknown
- 2015-06-17 CR CR20150321A patent/CR20150321A/es unknown
- 2015-06-18 EC ECIEPI201526203A patent/ECSP15026203A/es unknown
-
2016
- 2016-04-29 HK HK16104914.7A patent/HK1216856A1/zh unknown
-
2019
- 2019-12-16 US US16/716,205 patent/US11147764B2/en active Active
-
2020
- 2020-02-10 DO DO2020000031A patent/DOP2020000031A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015129310A (ru) | Таблетки с улучшенным приёмом и хорошей устойчивостью при хранении | |
| HRP20231060T1 (hr) | Pripravci peptida glp-1 i njihova priprava | |
| JP2015533134A5 (ru) | ||
| RU2019110089A (ru) | Усовершенствованная машина и способ упаковки в растягивающуюся пленку изделий, подаваемых блоками или по отдельности | |
| EA200901146A1 (ru) | Твердые лекарственные формы, содержащие алискирен и его фармацевтически приемлемые соли | |
| FI3769765T3 (fi) | Natriumalkyylisulfaattia sisältävä farmaseuttinen koostumus | |
| RU2017134562A (ru) | Сложный фармацевтический состав, включающий амлодипин, лозартан и хлорталидон | |
| DE602005019672D1 (de) | Getrocknetes Extrakt aus mit Vaccinia-Viren geimpfter, entzündeter Kaninchenhaut und Prozess zur Herstellung | |
| JP2007023015A5 (ru) | ||
| JP2016503767A5 (ru) | ||
| RU2012124704A (ru) | Лекарственное средство на основе сухих экстрактов лекарственных растений и способ его получения (варианты) | |
| RU2016106328A (ru) | Противотуберкулезная стабильная фармацевтическая композиция в форме диспергируемой таблетки, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления | |
| JP6778051B2 (ja) | オセルタミビルリン酸塩含有医薬組成物 | |
| WO2015022559A1 (en) | Pharmaceutical composition containing rosuvastatin and ramipril | |
| RU2015141639A (ru) | Комбинированный лекарственный препарат в форме шипучих таблеток и способ его получения | |
| RU2011127052A (ru) | Способ лечения головокружения различного генеза, кинетозов и вегетососудистой дистонии (варианты) и лекарственное средство | |
| EA201190091A1 (ru) | Активируемый влагой способ грануляции | |
| RU2013130801A (ru) | Фармацевтическая композиция для лечения заболеваний суставов и костных тканей | |
| RU2018105703A (ru) | Новый состав премикса для животных на основе зилпатерола | |
| JP2019131614A (ja) | 固形製剤 | |
| RU2015143218A (ru) | Комбинированный препарат, содержащий валсартан и розувастатин кальция и способ его изготовления | |
| RU2564015C1 (ru) | Фармацевтическая композиция производных гаммааминомасляной кислоты для твердых капсул | |
| CN102657619A (zh) | 一种西咪替丁速溶颗粒及其制备方法 | |
| RU2019110098A (ru) | Твердый препарат абиратерона ацетата, полученный с использованием способа жидкостной грануляции | |
| RU2013139744A (ru) | Антацидное лекарственное средство и способы его получения (варианты) |